Palvella Therapeutics (PVLA) Free Cash Flow (QoQ) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -121.54% |
| Dec 31, 2025 | 37.56% |
| Sep 30, 2025 | -45.07% |
| Jun 30, 2025 | 19.74% |
| Mar 31, 2025 | -25.50% |
| Dec 31, 2024 | -96.68% |
| Sep 30, 2024 | -71.05% |
| Jun 30, 2024 | -45.46% |
| Mar 31, 2024 | -105.34% |
| Dec 31, 2023 | 309.81% |
| Sep 30, 2023 | 26.93% |
| Jun 30, 2023 | -21.85% |
| Mar 31, 2023 | 20.79% |
| Dec 31, 2022 | -58.55% |
| Sep 30, 2022 | 42.50% |
| Jun 30, 2022 | 33.33% |
| Mar 31, 2022 | -92.89% |
| Dec 31, 2021 | 16.41% |
| Sep 30, 2021 | -147.94% |
| Jun 30, 2021 | 343.93% |
| Mar 31, 2021 | 13.07% |
| Dec 31, 2020 | -107.95% |
| Sep 30, 2020 | 37.91% |
| Jun 30, 2020 | 36.46% |
| Mar 31, 2020 | -12.59% |
| Dec 31, 2019 | -17.59% |
| Sep 30, 2019 | -10.44% |
| Jun 30, 2019 | 23.40% |
| Mar 31, 2019 | -58.26% |
| Dec 31, 2018 | 34.47% |
| Sep 30, 2018 | -56.51% |
| Jun 30, 2018 | -130.34% |
| Mar 31, 2018 | 660.95% |
| Dec 31, 2017 | -115.79% |
| Sep 30, 2017 | 585.87% |
| Jun 30, 2017 | -128.08% |
| Mar 31, 2017 | 467.36% |
| Dec 31, 2016 | -84.62% |
| Sep 30, 2016 | 38.81% |
| Jun 30, 2016 | -414.84% |
| Mar 31, 2016 | 168.88% |
| Dec 31, 2015 | 23.81% |
| Sep 30, 2015 | -19.73% |
| Jun 30, 2015 | 14.22% |
| Sep 30, 2014 | 99.59% |
| Jun 30, 2014 | -711.88% |
| Mar 31, 2014 | -44,229.64% |
| Dec 31, 2013 | 78.99% |
| Sep 30, 2013 | -1,546.72% |